| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 14, 2026 | Sell(S) | 1.4M | $25.00 | $34.0M | 2.4M |
| Aug 14, 2026 | Sell(S) | 478K | $25.00 | $12.0M | 567K |
| Aug 14, 2026 | Sell(S) | 322K | $25.00 | $8.1M | 429K |
| Aug 13, 2026 | Sell(S) | 268K | $26.20 | $7.0M | 3.8M |
| Aug 13, 2026 | Sell(S) | 94K | $26.20 | $2.5M | 1.0M |
| Aug 13, 2026 | Sell(S) | 64K | $26.20 | $1.7M | 751K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001577014-26-000016) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Dyne Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.